Get started
Author

Thomas Berg

Observed names: T Berg, T. Berg
ORCID: 0000-0003-0003-6241
Observed ORCID: 0000-0003-0003-6241
OpenAlex ID: A5108664376
Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study
2023 · Devin Razavi-Shearer, Ivane Gamkrelidze, et al. · ˜The œLancet. Gastroenterology & hepatology · 441
Real‐world effectiveness and safety of glecaprevir/pibrentasvir for the treatment of chronic hepatitis C infection: data from the German Hepatitis C‐Registry
2019 · Thomas Berg, Uwe Naumann, et al. · Alimentary Pharmacology & Therapeutics · 73
Number of people treated for hepatitis C virus infection in 2014-2023 and applicable lessons for new HBV and HDV therapies
2025 · Homie A. Razavi, Imam Waked, et al. · Journal of Hepatology · 29
PDF
Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts
2026 · Cornelius Engelmann, Nipun Verma, et al. · Journal of Hepatology · 12
Evaluating Resmetirom Eligibility Among Patients with MASH: Insights from the German Steatotic Liver Disease-Registry
2025 · Eva Katharina Messer, David Petroff, et al. · Zeitschrift für Gastroenterologie · 8
Long-term outcomes after nucleos(t)ide analogue cessation in chronic hepatitis B – follow-up from the RETRACT-B cohort
2026 · Edo Dongelmans, Grishma Hirode, et al. · Journal of Hepatology · 7
Modeling the dynamics of hepatic metabolism: the predominance of 12-hour rhythmicity in metabolic adaptation
2026 · Madlen Matz-Soja, Christiane Körner, et al. · Cellular and Molecular Life Sciences · 5
[Long-term follow-up of chronic hepatitis C after treatment with recombinant interferon alpha-2a].
1994 · U Hopf, S Küther, et al. · PubMed · 4
1358 Distinct, Alcohol-modulated Effects of Pnpla3 Genotype on Progression of Chronic Hepatitis C
2011 · T. Müller, S. Buch, et al. · Journal of Hepatology · 3
PDF
Growth Differentiation Factor 15 (GDF-15) as a modulator of hepatic steatosis and fibrosis: insights from a 6-year retrospective cohort study
2026 · Nicole Anna Dietzel, Maria Schmidt, et al. · Frontiers in Medicine · 2
PDF
Intrahepatic cholangiocarcinoma as a unique subtype: key updates from current guidelines
2025 · Aaron Schindler, Timm Denecke, et al. · Journal of Cancer Research and Clinical Oncology · 2
PDF
Analysis of B-Scan Ultrasonography Using Neural Networks to Predict Risk of Fibrosis in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2026 · Josefine Stansch, Kien Vu Trung, et al. · Ultrasound in Medicine & Biology · 1
PDF
Life-style factors of patients with metabolic dysfunction-associated steatotic liver disease – Data from the German SLD-Registry
2026 · Andreas Geier, Martin A. Kabelitz, et al. · Zeitschrift für Gastroenterologie · 1
SAT-418-YI Indication of resmetirom in patients with metabolic dysfunction associated steatohepatitis in the real-world setting - data from the german SLD-registry
2025 · Eva Messer, David Petroff, et al. · Journal of Hepatology · 1
Prognostic Value of Liver Function and Tumor Burden Scores in Patients with HCC After Transarterial Radioembolization – Retrospective Single Center Analysis
2026 · Aaron Schindler, Anne Beeskow, et al. · Journal of Gastrointestinal Cancer
PDF
Corrigendum to “Development and validation of the A-TANGO organ failure score for acute-on-chronic liver failure in global cohorts” [J Hepatol 85 (2026) 91–105]
2026 · Cornelius Engelmann, Nipun Verma, et al. · Journal of Hepatology
Imaging biomarkers of liver hypertrophy after portal vein embolization in patients with liver tumors: cholestasis, arterial hyperperfusion, and splenic response
2026 · Anne B. Beeskow, Karoline Rucker, et al. · Abdominal Radiology
PDF
Resolved HBV Infection Is Not Associated With Liver‐Related Outcomes in Survival Analysis of Caucasians After HCV Cure
2026 · Laura Muana Wilhelm, Albrecht Stoehr, et al. · Liver International
Bone Mineral Density Does Not Predict Overall Survival in Patients with Advanced Hepatocellular Carcinoma: A Subanalysis of the SORAMIC Trial
2026 · Maximilian Thormann, Andreas Wienke, et al. · Digestive Diseases
Hyperlipasämie nach Therapie mit direkt antiviralen Arzneimitteln bei Patienten mit chronischer Hepatitis-C-Virusinfektion – Daten aus dem Deutschen Hepatitis C-Register (DHC-R)
2026 · Bernd Heinrich, Peter Buggisch, et al. · Zeitschrift für Gastroenterologie
Immune biomarkers predicting response to G-CSF in acute-on-chronic liver failure: results from a GRAFT trial sub-study
2026 · Katrin Splith, Nadja Berndt, et al. · Hepatology International
PDF
THU-212 Overweight, but not alcohol is associated with increased risk for advanced liver disease in patients with chronic hepatitis C infection- results from the german hepatitis C-registry (DHC-R)
2025 · Katharina Luise Hupa-Breier, Peter Buggisch, et al. · Journal of Hepatology
THU-238 Previous hepatitis B virus infection and the risk of liver-related complications in patients after HCV cure - Data on more than 6,000 patients from the german hepatitis C-registry (DHC-R)
2025 · Laura Muana Wilhelm, Peter Buggisch, et al. · Journal of Hepatology
OS-067-YI Long term outcomes after nucleos(t)ide analogue cessation – an extended follow up study from the RETRACT-B cohort
2025 · Edo J. Dongelmans, Grishma Hirode, et al. · Journal of Hepatology
Previous hepatitis B virus infection and the risk of liver-related complications in patients after HCV cure – Data on more than 6000 patients from the German Hepatitis C-Registry (DHC-R)
2025 · Laura Muana Wilhelm, Albrecht Stoehr, et al. · Zeitschrift für Gastroenterologie
Works count: 27
Citation count: 588
H-index: 6
I10-index: 4
Year
Topic
Type